• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Whole Genome Sequencing of A(H3N2) Influenza Viruses Reveals Variants Associated with Severity during the 2016⁻2017 Season

tetano

Editor, Senior Moderator
Viruses. 2019 Jan 28;11(2). pii: E108. doi: 10.3390/v11020108.
[h=1]Whole Genome Sequencing of A(H3N2) Influenza Viruses Reveals Variants Associated with Severity during the 2016⁻2017 Season.[/h] Simon B[SUP]1,[/SUP][SUP]2[/SUP], Pichon M[SUP]3,[/SUP][SUP]4,[/SUP][SUP]5[/SUP], Valette M[SUP]6,[/SUP][SUP]7,[/SUP][SUP]8[/SUP], Burfin G[SUP]9[/SUP], Richard M[SUP]10[/SUP], Lina B[SUP]11,[/SUP][SUP]12,[/SUP][SUP]13[/SUP], Josset L[SUP]14,[/SUP][SUP]15,[/SUP][SUP]16[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza viruses cause a remarkable disease burden and significant morbidity and mortality worldwide, and these impacts vary between seasons. To understand the mechanisms associated with these differences, a comprehensive approach is needed to characterize the impact of influenza genomic traits on the burden of disease. During 2016⁻2017, a year with severe A(H3N2), we sequenced 176 A(H3N2) influenza genomes using next generation sequencing (NGS) for routine surveillance of circulating influenza viruses collected via the French national influenza community-based surveillance network or from patients hospitalized in the intensive care units of the University Hospitals of Lyon, France. Taking into account confounding factors, sequencing and clinical data were used to identify genomic variants and quasispecies associated with influenza severity or vaccine failure. Several amino acid substitutions significantly associated with clinical traits were found, including NA V263I and NS1 K196E which were associated with severity and co-occurred only in viruses from the 3c.2a1 clade. Additionally, we observed that intra-host diversity as a whole and on a specific set of gene segments increased with severity. These results support the use of whole genome sequencing as a tool for the identification of genetic traits associated with severe influenza in the context of influenza surveillance.


[h=4]KEYWORDS:[/h] NGS; epidemiology; influenza; quasispecies; severity; vaccination

PMID: 30695992 DOI: 10.3390/v11020108
Free full text
 
Back
Top Bottom